OMRON is unveiling a new automatic wrist blood pressure monitor specifically designed and validated for obese patients. The OMRON RS7 Intelli IT is planned to go on sale in Europe for €99 later this year.
In order to guarantee accuracy of BP measurements, the new device has a special LED position sensor that helps to make sure the cuff is placed correctly over the wrist. Once activated, the device can produce not only blood pressure readings, but can also indicate irregular hearbeats, CWG, body movement detection, and average function. There’s also a smartphone app that the OMRON RS7 Intelli IT can connect to in order to store readings and share them with others.
The system has been tested against clinical blood pressure monitors, showing equivalent results. This is an important development, as accurately measuring blood pressure in heavy people can be a challenge and readings can be misleading. OMRON presented these findings at the European Society of Cardiology Congress earlier this week in Munich, Germany.
In addition to the RS7 Intelli IT, OMRON will launch later this year a whole new range of wrist devices, of which the OMRON RS4 is also clinically validated for use in obese populations and features different functions that address various needs and lifestyles. The whole range is easy to use on the wrist, tubeless, small and portable, ideal for travelling, sleek and compact.
This new technology is part of a series of developments deeply rooted in OMRON’s Japanese heritage of innovation. Designing wearables to be used on the go, OMRON is enabling patients to get real-time insights on their situation, so that they can be in control of their body and make appropriate medical and lifestyle decisions so that they live with zero compromise on health.